This learning programme has been developed for healthcare professionals who manage lipid modification, this may include GPs, practice nurses, community pharmacists and primary care pharmacists.
To examine the NICE guideline recommendations for cardiovascular risk assessment and lipid modification and to apply the knowledge you’ve gained to practice. This e-learning tool will take you about one hour to complete.
The NICE Lipid modification Clinical guideline 181 was published in July 2014. Currently one in three deaths in the UK are caused by CVD, accounting for 180,000 deaths each year. The lipid modification guideline recommends lifestyle modification and/or statin treatment to reduce cardiovascular risk.
This e-learning tool has case studies and activities to help you implement the NICE guideline, identify the key changes for practice and focus on the key implementation challenges identified. It is divided into five sections: Introduction, assessment of cardiovascular risk, lifestyle modification, statin treatment and communicating risk.